Some good news on the Cytokine Storm front. Small trial out of India, but it’s an already approved medicine so we already know it’s safe. Maybe it’ll work better than tocilizumab.
“In the patients receiving itolizumab, there were zero deaths and all patients have recovered. In the control arm, three patients died, and the rest have recovered. This mortality benefit was statistically significant. Patients receiving itolizumab demonstrated significant decreases in inflammatory cytokines such as IL-6 and TNFalpha.”
https://www.biospace.com/article/eq...cuts-death-in-hospitalized-covid-19-patients/
Meanwhile, Leronlimab was rejected from the FDA. Might not be anything serious, but a lot of mystery around this drug
https://www.statnews.com/2020/07/13/fda-refuses-cytodyn-hiv-drug-application/